PARIS–(BUSINESS WIRE)–Spotlight Medical, a company developing AI-powered prognostic tests in oncology, today announced results from an independent evaluation of myStage Dx, its CE-IVDR-marked test for assessing recurrence risk in patients with hormone receptor-positive, HER2-negative early breast cancer. The study was conducted by researchers at Karolinska Institutet in Sweden. Independent, Blinded Evaluation Using Phase III Trial Data The study used data from 620 patients enrolled in PANTHER

LONDON–(BUSINESS WIRE)–      DMO-TAS031/3748/003 The Minster Building21 Mincing LaneLondonEC3R 7AG T 020 7862 6500F 020 7862 6509www.dmo.gov.uk         22 October 2026 A14226   PRESS NOTICE   RESULT OF THE SALE BY AUCTION OF £1,000 MILLION OF 0⅛% INDEX-LINKED TREASURY GILT 2031The United Kingdom Debt Management Office (“DMO”) announces that the auction of £1,000 million of 0⅛% Index-Linked Treasury Gilt 2031 (ISIN code: GB00BNNGP551) has been allocated as follows:(Note: all prices in this no

LONDON–(BUSINESS WIRE)–  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be

LONDON–(BUSINESS WIRE)–  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, t

LONDON–(BUSINESS WIRE)–  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

ZÜRICH–(BUSINESS WIRE)–Auf der it-sa Expo&Congress 2026 (27. bis 29. Oktober, Messe Nürnberg) präsentiert Exeon Analytics, ein Schweizer Unternehmen für Cybersecurity-Software, seine neuesten Produktentwicklungen für KI-gesteuerte Bedrohungserkennung und Verhaltensanalysen. Das Unternehmen zeigt, wie seine Lösungen von Exeon.NDR und Exeon.UEBA Unternehmen dabei helfen, zwei zunehmend kritische Sicherheitsherausforderungen zu bewältigen: den Schutz geschäftskritischer SAP-Umgebungen und di

LONDON–(BUSINESS WIRE)–  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

TOKYO–(BUSINESS WIRE)–Unicharm Corporation (TOKYO: 8113) announced the full-scale operation of its East African joint venture with Toyota Tsusho Corporation, “SOFY UNICHARM EAST AFRICA LIMITED.” To mark this milestone, Unicharm held a business presentation and inauguration ceremony in Nairobi, Kenya, on October 14, 2026. The event, attended by local distributors, business partners, and government officials, highlighted the company’s strategic shift to a direct sales system and outlined its am

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.